FIG 3.

Clinical scores (means ± SDs) for the AFX- and IVM-treated and control pigs over time from scabies infection to the study end. The manifestation of scabies infestation in the skin areas of five anatomic sites (ears, legs, tail, back, and head) was monitored weekly. Clinical scores are based on the skin surface affected by scabies lesions (scored 0 to 6: 0, 0%; 1, <10%; 2, 10% to 29%; 3, 30% to 49%; 4, 50% to 69%; 5, 70% to 89%; 6, 90% to 100%), intensity of skin erythema (scored 0 to 4: 0, no erythema; 1, mild; 2, moderate; 3, severe; 4, extremely severe), and the encrustment intensity (scored 2× as 0 to 4: 0, no crust; 1, gray to white, thin and irregular 1- to 2-mm crust; 2, 2- to 5-mm crust; 3, gray-brown >5-mm crust; and 4, >5-mm hard crust). The score was calculated for the 5 different anatomic sites and added. W, week; D, day; AFX, afoxolaner; IVM, ivermectin.